Alnylam Pharmaceuticals Inc.

In News

Assessing Alnylam Pharmaceuticals (ALNY) Valuation After New Cardiovascular Partnership With Tenaya Therapeutics - simplywall.st

simplywall.st - Mar 07, 2026

Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal - Pharmaceutical Technology

Pharmaceutical Technology - Mar 06, 2026

Alnylam Updates Hypertension Pipeline And AMVUTTRA Access Shape Valuation View - Sahm

Sahm - Mar 06, 2026

Biotech duo chases new heart disease genes in $1.13B research pact - Stock Titan

Stock Titan - Mar 05, 2026

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness - Yahoo Finance

Yahoo Finance - Mar 07, 2026

Tenaya Therapeutics Enters into Research Collaboration with - GlobeNewswire

GlobeNewswire - Mar 05, 2026

Alnylam Pharmaceuticals grants performance-based equity award to CEO - Investing.com

Investing.com - Mar 04, 2026

Alnylam’s research pact worth up to $1.1B sends Tenaya higher - Seeking Alpha

Seeking Alpha - Mar 05, 2026

Tenaya Therapeutics Stock Jumps After New Alnylam Deal - Benzinga

Benzinga - Mar 05, 2026

Helix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine Development - PR Newswire

PR Newswire - Mar 05, 2026

Tenaya, Alnylam join in $1B+ cardio deal for novel genetic targets - BioWorld MedTech

BioWorld MedTech - Mar 05, 2026

Tenaya To Evaluate Genetic Cardiovascular Targets For Alnylam - Citeline News & Insights

Citeline News & Insights - Mar 05, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment